|
|
|
|
/RXR Pathway in Chickens and HD11 Cell Lines1
Department of Animal Science, University of California, Davis, CA 95616
2 To whom correspondence should be addressed. Email: kcklasing{at}ucdavis.edu.
Two experiments were conducted to investigate the effect of lutein and fat or eicosapentaenoic acid (EPA) interaction on inducible nitric oxide synthase (iNOS), PPARs
, ß, and
, and retinoic acid X receptor (RXR)
and
mRNA levels. In Expt. 1, macrophages were collected from broiler chicks fed 3 or 6% dietary fat (g/100 g) with 0, 25, and 50 mg lutein/kg feed for 23 d. In Expt. 2, using a 3 x 3 factorial, eicosapentaenoic acid (EPA) at 0, 15 and 50µmol/L and lutein at 0, 10 and 100µmol/L were applied to HD11 cell culture for 24 h. In both experiments, cells were stimulated with lipopolysaccharide before RNA isolation. Lutein interacted with fat in Expt. 1 and with EPA in Expt. 2 to affect mRNA levels of iNOS, PPAR
, and RXR
in chicken macrophages and HD11 cells, respectively (P < 0.05). At 3% dietary fat or up to 15 µmol/L EPA in the medium, increasing lutein increased the iNOS mRNA. However, at 6% dietary fat or 50 µmol/L EPA, lutein did not cause a rise in iNOS mRNA. Increasing lutein in the medium from 0 to 100 µmol/L decreased iNOS mRNA. Increasing lutein with high fat (6%) or EPA (15 µmol/L EPA) increased PPAR
and RXR
mRNA levels. Lutein increased PPAR
mRNA levels in both macrophages (P < 0.01) and HD11 (P = 0.01) cells and RXR
(P < 0.01) mRNA levels in macrophages. GW9662, a PPAR
antagonist, prevented (P < 0.01) the lutein-induced iNOS mRNA downregulation in HD11 cells. LG101208, a RXR antagonist, prevented (P < 0.01) iNOS upregulation induced by 10 µmol/L lutein and iNOS mRNA downregulation induced by 100 µmol/L lutein. We conclude that lutein and EPA interact through the PPAR
and RXR pathways to modulate iNOS mRNA.
KEY WORDS: lutein fat eicosapentaenoic acid nuclear receptors
This article has been cited by other articles:
![]() |
R. S. Deeb, R. K. Upmacis, B. D. Lamon, S. S. Gross, and D. P. Hajjar Maintaining Equilibrium by Selective Targeting of Cyclooxygenase Pathways: Promising Offensives Against Vascular Injury Hypertension, January 1, 2008; 51(1): 1 - 7. [Full Text] [PDF] |
||||
![]() |
T. Koto, N. Nagai, H. Mochimaru, T. Kurihara, K. Izumi-Nagai, S. Satofuka, H. Shinoda, K. Noda, Y. Ozawa, M. Inoue, et al. Eicosapentaenoic Acid Is Anti-Inflammatory in Preventing Choroidal Neovascularization in Mice Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4328 - 4334. [Abstract] [Full Text] [PDF] |
||||